Director, US Medical Oncology, Non-Metastatic Lung Cancer Portfolio

At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

Position Summary

Position reports to the Executive Director of US Medical Oncology, Thoracic & Emerging Tumors. This role will have accountability as the US market Medical Lead for the thoracic non-metastatic cancer portfolio, and lead the US Medical matrix teams to set the medical strategies and objectives on data generation, communication, publication, etc. The Director will oversee the execution of medical activities to increase knowledge to ensure safe/effective use of BMS products and translate clinical insights into actionable strategies and tactics to meet customers’ needs. This Director role is responsible for partnering with US Commercialization, collaborating with WW Medical, Clinical Development, and HEOR teams to pursue a strategic vision for the product lifecycle within the disease area.

Key Responsibilities

• Establish clear and challenging goals that allow skilled and empowered professionals to accomplish business objectives consistent with organization; make objective and effective decision.

• Lead the development of US medical plan that is both product and disease specific in alignment with US Commercialization (USC) and WW Medical (WWM), translating USC and WWM strategies into effective US Medical launch plans and life cycle management plans.

• Active leadership and participation as core member on the nmNSCLC Worldwide medical matrix team, and closely collaborating/partnering with worldwide counterparts to craft the WWM plan that ensures US market needs are addressed.

• Establish US Medical data generation strategies and collaborate with Medical Data Generation (MDG) to oversee the execution of the Investigator Sponsored Research (ISR) programs from concept through full execution, including reporting the evidence at scientific congresses, in peer reviewed publications, and proactive/reactive BMS communication tools.

• Co-Lead US Medical matrix teams (Field Medical, Data Generation, Patient Advocacy, Medical Education, and Congress Management) to plan and deliver medical objectives with flawless execution and excellence budget utilization. Measures and assess the effectiveness of US Medical plans regularly.

• Partner closely with colleagues in Discovery, Clinical Research, Regulatory, and Health Outcomes to ensure the science of the pipeline products and marketed medicines are understood and communicated properly internally and externally.

• Collaborate and communicates with US Commercialization & Access organizations to integrate medical perspectives into the commercialization process and ensure appropriate alignment between commercial and medical plans.

• Engage with high impact external thought leaders, across a number of disciplines, in order to identify and translate key insights and to drive adoption of BMS medicines.

• Contribute to shaping the competitive strategies around pricing and reimbursement by influencing from US perspective for the target product profile, label language and value considerations.

• Manage, coach, and develop a team of Medical Scientists and/or MD or PharmD fellows (if applicable).

• Serve as internal disease expert who is fully integrated into the BMS matrix team and provides critical input into the development of effective communication tools and programs for optimal market access.

• Demonstrate the ability to make effective decisions on selecting external organizations and researchers with appropriate expertise for research collaborations.

• Advanced scientific degree (MD, PhD, PharmD, DNP)

• Minimum 8 years of pharmaceutical industry or other relevant experience in Oncology is preferred

• Highly organized and motivated individual with the ability to lead multiple projects and initiatives across diverse high performing matrix teams

• The successful candidate must have the ability to work effectively within cross-functional teams, have excellent communication and presentation skills, both verbal and written

• They should have an understanding of pharmaceutical drug development including clinical development, regulatory, life cycle management of pharmaceutical products, and knowledge of thought leaders in the field

• Ability to lead and develop people

• Strong interpersonal and communication skills to navigate complex situations and gain alignment with diverse stakeholders

• Demonstrated ability to execute and deliver results in a deadline-driven environment while managing multiple priorities

• Strong understanding of business acumen including payer and market access challenges

• Estimated 30% travel (as applicable)

#LI-Hybrid

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Physical presence at the BMS worksite or physical presence in the field is an essential job function of this role which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and enhances the Company culture.

To protect the safety of our workforce, customers, patients and communities, the policy of the Company requires all employees and workers in the U.S. and Puerto Rico to be fully vaccinated against COVID-19, unless they have received an exception based on an approved request for a medical or religious reasonable accommodation. Therefore, all BMS applicants seeking a role located in the U.S. and Puerto Rico must confirm that they have already received or are willing to receive the full COVID-19 vaccination by their start date as a qualification of the role and condition of employment. This requirement is subject to state and local law restrictions and may not be applicable to employees working in certain jurisdictions such as Montana. This requirement is also subject to discussions with collective bargaining representatives in the U.S.

Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or if you are applying to a role based in the U.S. or Puerto Rico and you believe that you are unable to receive a COVID-19 vaccine due to a medical condition or sincerely held religious belief, during or any part of the recruitment process, please direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.

BMS will consider for employment qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.

Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.